WebJMP Securities Adjusts Price Target on Marinus Pharmaceuticals to $18 From $19, Maintains Market Outperform Rating. MT Newswires. 03/08 10:11. RBC Trims Price Target on Marinus Pharmaceuticals to $22 From $23, Maintains Outperform, Speculative Risk. MT Newswires. Web"Marinus Pharmaceuticals Inc" yra Jungtinėse Amerikos Valstijose įsikūrusi biofarmacijos bendrovė. Bendrovė kuria ir komercializuoja medicininius vaistus, skirtus rimtiems neurologiniams ir psichiatriniams sutrikimams, tokiems kaip epilepsija, potrauminis stresas ir "fragile-x" sindromas, gydyti.
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals to …
WebMARINUS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) Best Stocks 2 days ago Marinus … WebMarinus Pharmaceuticals, Inc. Common Stock (MRNS) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts Key Data Bid Price and Ask Price The bid & ask... disko skole
Marinus Pharmaceuticals, Inc. - AnnualReports.com
Web31 dec. 2024 · RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative … Web7 apr. 2024 · RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to five new employees.The Compensation Committee of the Board of Directors of Marinus … Web23 feb. 2024 · Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric... bebe 7 semanas e 5 dias